CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,939
- in 3 filings, $45K under 10b5-1 plans
Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | Greenleaf Peter Director | Sale 10b5-1 | −797 | $21.17 | $17K | 23,087 |
| 2026-07-02 | Greenleaf Peter Director | Sale 10b5-1 | −712 | $26.00 | $19K | 23,969 |
| 2026-07-02 | Greenleaf Peter Director | Sale 10b5-1 | −85 | $27.27 | $2K | 23,884 |
| 2026-04-02 | Greenleaf Peter Director | Sale 10b5-1 | −420 | $20.52 | $9K | 25,058 |
| 2026-04-02 | Greenleaf Peter Director | Sale 10b5-1 | −377 | $21.36 | $8K | 24,681 |
| 2025-07-02 | Greenleaf Peter Director | Grant or award | +25,478 | 25,478 | ||
| 2025-07-02 | Greenleaf Peter Director | Grant or award · Restricted Stock Units | +25,478 | 25,478 | ||
| 2025-07-02 | Greenleaf Peter Director | Grant or award · Stock Option | +77,640 | 77,640 |
Page 1 of 1 · 8 trades